Health TrialsbyHealthPanel

Effect of Different Hyaluronic Acids in the Treatment of Subdeltoid Bursitis

ConditionSubdeltoid Bursitis of the Shoulder
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age20+
SponsorShin Kong Wu Ho-Su Memorial Hospital

About this trial

The study employs a double-blind, randomized clinical trial design with 50 patients diagnosed with subdeltoid bursitis. Participants are divided into two groups: ultra-high-molecular-weight hyaluronic acid or high-molecular-weight hyaluronic acid injection. All injections are guided by ultrasound. Assessments are conducted before treatment and at 1 week, 1 month, and 3 months post-treatment.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • ultra-high molecular weight hyaluronic acid injection

    Drug

    ultra-high molecular weight hyaluronic acid

  • high molecular weight hyaluronic acid injection

    Drug

    Ultrasound-guided injection into subdeltoid bursa

Treatment groups

52 Participants
are divided into 2 treatment groups
Group A: ultra-high molecular weight hyaluronic acidExperimental treatment 1 intervention
Group B: high molecular weight hyaluronic acidActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Shoulder Pain and Disability Index

A questionnaire to evaluate the severity of shoulder pain and disability in patients with shoulder problems; higher scores indicated more significant pain and disability

Time frame
Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome

Secondary outcomes

1

Disabilities of the Arm, Shoulder, and Hand

The questionnaire measures physical function and symptoms in people with upper-limb disorders, including conditions affecting the shoulder, elbow, wrist, or hand. The score ranges from 0 to 100: 0 = no disability; 100 = most severe disability

Time frame
Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome
2

Range of motions of shoulder joint

Range of motion of the shoulder joint

Time frame
Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome
3

World Health Organization Quality of Life

Assesses 4 key domains: Physical Health, Psychological , Social Relationships and Environment, score ranges 0-100, higher score indicates greater health

Time frame
Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome
4

visual analog scale

Measuring subjective pain intensity, score ranges from 0 to 10 (or 0 to 100 mm, depending on format), the higher score indicates more severe symptom

Time frame
Score change from baseline to 1 week, 1 months and 3 months of treatment, higher score, the better outcome

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Shin Kong Wu Ho-Su Memorial Hospital

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: